Examine publishes rigorous, unbiased analysis of the latest and most important nutrition and supplementation studies each month, available to all Examine Members. Click here to learn more or log in.

Quick Navigation

Issue #23 (September 2016)

Letter from the Editor

Articles in this issue

  • Gut bugs and arthritis
    Hippocrates said “all disease begins in the gut”, which might be close to the truth. This research looked at a type of gut bacteria that may help protect against rheumatoid arthritis
  • HMB + ATP = huge muscles?
    HMB (short for β-Hydroxy β-Methylbutyrate) has shown promise in limited trials looking at its free acid form. Could combining this form with ATP be a recipe for accelerated muscle gain?
  • Rematch: EPA vs. DHA for cardiovascular risk factors
    NERD #21 already examined the effect of EPA vs. DHA in very high doses. This randomized trial answers whether normal doses of either fatty acid could help inflammation and blood lipids.
  • A review of carnitine and weight loss
    The amino acid l-carnitine has been studied for weight loss, with confusingly mixed results. Researchers pooled previous studies together in this meta-analysis to get a clearer picture.
  • Interview: Pablo Sanchez-Soria, PhD
    Toxins: a term that's incredibly overused by people who typically don't understand the concepts very well. Dr. Sanchez-Soria is a toxicologist who deals with toxins and disease on a daily basis. Dr. Pablo Sanchez-Soria is a Toxicologist at the Center for Toxicology and Environmental Health, L.L.C. (CTEH®). Dr. Sanchez-Soria has experience in the fields of human and environmental toxicology, as well as molecular and systems toxicology with an emphasis in cardiovascular and metabolic diseases.
  • Kids will be kids … even if they skip breakfast?
    Kids always get bugged by their parents to eat breakfast, so that they can do well in school. But does breakfast consumption actually impact cognition in this population?
  • Have the fructose alarm bells rang too soon? Open Access
    Fructose is both highly controversial and highly researched. Yet until this recent trial, it hadn’t been compared to other sugars for inflammation and intestinal impacts.
  • All the data on resveratrol for cardiovascular health
    With 21 existing randomized trials looking at resveratrol’s effect on cardiovascular health markers, this meta-analysis was needed to summarize the data and get a sense of how much, if any, it may help.
See all issues of Study Deep Dives